The present invention relates to an amorphous form of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methylacetamide, methods for its preparation, its use as a therapeutically active agent and pharmaceutical compositions comprising the novel form.